Keystone Symposia
Home | My Account | Shopping Cart  0
  Advanced
     facebook  twitter

NOTE: This meeting occurs in 2011 (June 20 - 25, 2011)

LANGUAGE NOTE: This meeting will be conducted in English.
**Registration currently unavailable: **


Meeting Program

To view program in "24 hour" time (international) click here.


Monday, June 20
3:00 - 7:30 PM Registration Imperial Check Room
6:30 - 7:30 PM Refreshments Plaza Ballroom
7:30 - 8:30 PM Keynote Address
Registered attendees for this meeting can view Abstracts for this session starting on 05/20/2011
Imperial Ballroom
Tom Hudson, Ontario Institute for Cancer Research, Canada
Large-Scale Cancer Genomics
Tuesday, June 21
7:30 - 8:30 AM Breakfast Plaza Ballroom
8:30 AM- 12:00 PM Large-Scale Cancer Genome Projects
Registered attendees for this meeting can view Abstracts for this session starting on 05/20/2011
Imperial Ballroom
Lynda Chin, Dana-Farber Cancer Institute, TCGA, USA
GBM
Andy Futreal, Wellcome Trust Sanger Institute, UK
Breast
Matthew L. Meyerson, Dana-Farber Cancer Institute, TCGA, USA
Somatic Genome Alterations in Human Lung Cancer
James R. Downing, St. Jude Children's Research Hospital, USA
Pediatric Leukemia/Medulloblastoma
Short Talk(s) to be Chosen from Abstracts,
9:40 - 10:00 AM Coffee Break Imperial Foyer
11:30 AM- 1:00 PM Poster Setup Plaza Ballroom
1:00 - 10:00 PM Poster Viewing Plaza Ballroom
3:00 - 4:30 PM Workshop 1: Genome Technologies
Imperial Ballroom
Short Talks to be Chosen from Abstracts, ,
- ABI/SoLID, Illumina, Roche/454, - Pacific Biosciences, Complete Genomics, - Visigen
4:30 - 5:00 PM Coffee Available Imperial Foyer
5:00 - 7:00 PM Genome Technologies: Current State and 3rd Generation
Registered attendees for this meeting can view Abstracts for this session starting on 05/20/2011
Imperial Ballroom
Stacey Gabriel, Broad Institute, USA
Overview of State of NGS and Where We Are Going with Next NGS
Speakers to be Announced,
Short Talk to be Chosen from Abstracts,
7:00 - 8:00 PM Social Hour w/ Lite Bites Plaza Ballroom
7:30 - 10:00 PM Poster Session 1
Registered attendees for this meeting can view Abstracts for this session starting on 05/20/2011
Plaza Ballroom
Wednesday, June 22
7:30 - 8:30 AM Breakfast Plaza Ballroom
7:30 - 8:30 AM Poster Setup Plaza Ballroom
8:30 AM- 5:00 PM Poster Viewing Plaza Ballroom
8:30 AM- 12:00 PM Cancer Genome Analysis: Bioinformatics
Registered attendees for this meeting can view Abstracts for this session starting on 05/20/2011
Imperial Ballroom
Peter Campbell, Wellcome Trust Sanger Institute, UK
Mutation and Indel Calling
Speaker to be Announced,
Short Talk to be Chosen from Abstracts,
Gaddy Getz, Broad Institute, USA
Structure of Genome at Break Points/Rearrangement
Speaker to be Announced,
Genome Assembly
Short Talk to be Chosen from Abstracts,
9:40 - 10:00 AM Coffee Break Imperial Foyer
11:30 AM- 12:30 PM Lunch Plaza Ballroom
12:00 - 3:00 PM Poster Session 2
Registered attendees for this meeting can view Abstracts for this session starting on 05/20/2011
Plaza Ballroom
3:00 - 4:30 PM Workshop 2: Genome Analysis
Imperial Ballroom
Short Talks to be Chosen from Abstracts, ,
- TCGA Analysis Pipeline, - ICGC Analysis, - USCS Browser, - MSKCC
4:30 - 5:00 PM Coffee Available Imperial Foyer
5:00 - 7:00 PM Cancer Genome Analysis: Algorithm Development and Network Modeling
Registered attendees for this meeting can view Abstracts for this session starting on 05/20/2011
Imperial Ballroom
Andrea Califano, Columbia University, USA
Title to be Determined
Speaker to be Announced,
Iya G. Khalil, Gene Network Sciences, USA
Therapeutically-Driven Network Models of Cancer
Short Talk to be Chosen from Abstracts,
7:00 PM- On Own for Dinner
Thursday, June 23
7:30 - 8:30 AM Breakfast Plaza Ballroom
8:30 AM- 12:00 PM Large-Scale Cancer Genome Projects
Registered attendees for this meeting can view Abstracts for this session starting on 05/20/2011
Imperial Ballroom
Victor E. Velculescu†, Johns Hopkins University, USA
Talk Title to be Determined
Speaker to be Announced,
Richard Wilson, Washington University School of Medicine, USA
Talk Title to be Determined
Jessica Zucman-Rossi, INSERM U674, France
HCC
Short Talk(s) to be Chosen from Abstracts,
9:40 - 10:00 AM Coffee Break Imperial Foyer
11:00 AM- 1:00 PM Poster Setup Plaza Ballroom
1:00 - 10:00 PM Poster Viewing Plaza Ballroom
11:30 AM- On Own for Lunch and Recreation
4:30 - 5:00 PM Coffee Available Imperial Foyer
5:00 - 7:00 PM Genome Biology
Registered attendees for this meeting can view Abstracts for this session starting on 05/20/2011
Imperial Ballroom
Michael Stratton, Wellcome Trust Sanger Institute, UK
Pattern Somatic Mutations in Cancer and Progression
Franziska Michor, Memorial Sloan-Kettering Cancer Center, USA
Evolution of the Cancer Genome
Todd R. Golub, Broad Institute, USA
Genomics of Cancer Progression and Metastasis
Short Talk to be Chosen from Abstracts,
7:00 - 8:00 PM Social Hour w/ Lite Bites Plaza Ballroom
7:30 - 10:00 PM Poster Session 3
Registered attendees for this meeting can view Abstracts for this session starting on 05/20/2011
Plaza Ballroom
Friday, June 24
7:30 - 8:30 AM Breakfast Plaza Ballroom
8:30 AM- 12:00 PM Beyond the Genomes
Registered attendees for this meeting can view Abstracts for this session starting on 05/20/2011
Imperial Ballroom
Peter W. Laird, University of Southern California/Norris Comprehensive Cancer Center, USA
Epigenomics/Methylation
Marc Vidal†, Dana-Farber Cancer Institute, USA
Protein Interactome
Short Talk to be Chosen from Abstracts,
Arul M. Chinnaiyan, University of Michigan, USA
Metabolomics
Speaker to be Announced,
Higher Order Chromatin/Chromosome Structure
Short Talk to be Chosen from Abstracts,
9:40 - 10:00 AM Coffee Break Imperial Foyer
3:00 - 4:30 PM Workshop 3: Late Breaking Developments
Short Talks to be Chosen from Abstracts, ,
4:30 - 5:00 PM Coffee Available Imperial Foyer
5:00 - 7:00 PM Cancer Genomics and Drug Discovery
Registered attendees for this meeting can view Abstracts for this session starting on 05/20/2011
Imperial Ballroom
Christoph Lengauer, Sanofi-Aventis, France
What is Needed to Convert a Genomic Target to a Therapeutic Target?
Barbara L. Weber, Novartis, USA
Genomics-Based Biomarker Discovery
Short Talk to be Chosen from Abstracts,
Giulio F. Draetta, Dana-Farber Cancer Institute, USA
Bridging the Gap between Cancer Genomics and Drug Discovery
8:00 - 11:00 PM Entertainment Plaza Ballroom
Saturday, June 25
Departure
      *=Session Chair     †=Speaker invited, not yet responded.



Keystone Symposia would like to thank the sponsors of this meeting for their generous support:

We gratefully acknowledge additional support for this conference from:



We gratefully acknowledge the organizations that provide Keystone Symposia with additional support, such as marketing and advertising...

Click here to view these companies

Large scale cancer-genomics across the globe are capturing increasingly detailed views of the cancer genomes. These data have the potential to transform every aspect of cancer research. The challenges now are to decipher what the genomic landscape is teaching us about the initiation, progression and clinical behavior of a tumor. The goals of this meeting are (1) to bring together the data producers and analysts to share their latest findings, both technical and biological, from large-scale cancer genomic projects and address the challenges in analyses of these complex cancer genomic data; (2) to highlight how these genomic data are enabling a system/network-view of the genome and how the patterns of mutations are teaching new insight into underlying etiologies; and (3) to explore how cancer genomics can impact on drug discovery and development.